×
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
S&P 500   3,831.39 (+0.16%)
DOW   30,967.82 (-0.42%)
QQQ   286.96 (+1.71%)
AAPL   141.56 (+1.89%)
MSFT   262.85 (+1.26%)
META   168.19 (+5.10%)
GOOGL   2,265.26 (+4.16%)
AMZN   113.50 (+3.60%)
TSLA   699.20 (+2.55%)
NVDA   149.64 (+3.04%)
NIO   22.18 (+3.84%)
BABA   120.13 (+3.56%)
AMD   75.20 (+2.08%)
MU   56.73 (+5.74%)
CGC   2.71 (-3.56%)
T   21.17 (-0.66%)
GE   62.03 (-2.38%)
F   11.20 (-1.06%)
DIS   97.18 (+1.08%)
AMC   12.78 (-5.54%)
PFE   51.64 (-1.28%)
PYPL   74.40 (+4.20%)
NFLX   185.88 (+3.30%)
NYSE:OSCR

Oscar Health Stock Forecast, Price & News

$4.88
+0.31 (+6.78%)
(As of 07/5/2022 05:46 PM ET)
Add
Compare
Today's Range
$4.41
$4.88
50-Day Range
$4.06
$7.76
52-Week Range
$3.89
$21.18
Volume
1.44 million shs
Average Volume
1.93 million shs
Market Capitalization
$1.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Oscar Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
94.7% Upside
$9.50 Price Target
Short Interest
Bearish
9.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.11mentions of Oscar Health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$154,538 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.58) to ($1.66) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.63 out of 5 stars

Finance Sector

674th out of 1,398 stocks

Hospital & Medical Service Plans Industry

9th out of 13 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive OSCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oscar Health and its competitors with MarketBeat's FREE daily newsletter.

About Oscar Health

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

OSCR Stock News Headlines

Oscar Health (NYSE:OSCR) Shares Gap Down to $4.19
4 Analysts Have This to Say About Oscar Health
See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
2,621
Year Founded
N/A

Company Calendar

Last Earnings
5/10/2022
Today
7/05/2022
Next Earnings (Estimated)
8/11/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$4.50
Forecasted Upside/Downside
+94.7%
Consensus Rating
Hold
Rating Score (0-4)
2
Research Coverage
6 Analysts

Profitability

Net Income
$-572,610,000.00
Pretax Margin
-22.87%

Debt

Sales & Book Value

Annual Sales
$1.84 billion
Book Value
$6.65 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.03 billion
Optionable
Not Optionable
Beta
0.69














Oscar Health Frequently Asked Questions

Should I buy or sell Oscar Health stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Oscar Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSCR, but not buy additional shares or sell existing shares.
View analyst ratings for Oscar Health
or view top-rated stocks.

What is Oscar Health's stock price forecast for 2022?

6 brokerages have issued 12 month price objectives for Oscar Health's stock. Their OSCR stock forecasts range from $4.50 to $15.00. On average, they predict Oscar Health's share price to reach $9.50 in the next year. This suggests a possible upside of 94.7% from the stock's current price.
View analysts' price targets for Oscar Health
or view top-rated stocks among Wall Street analysts.

How has Oscar Health's stock performed in 2022?

Oscar Health's stock was trading at $7.85 at the beginning of the year. Since then, OSCR shares have decreased by 37.8% and is now trading at $4.88.
View the best growth stocks for 2022 here
.

When is Oscar Health's next earnings date?

Oscar Health is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Oscar Health
.

How were Oscar Health's earnings last quarter?

Oscar Health, Inc. (NYSE:OSCR) issued its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.04. Oscar Health had a negative trailing twelve-month return on equity of 37.23% and a negative net margin of 22.93%. During the same quarter in the previous year, the business posted ($0.98) earnings per share.
View Oscar Health's earnings history
.

Who are Oscar Health's key executives?

Oscar Health's management team includes the following people:
  • Mr. Mario Tobias Schlosser, Co-Founder, CEO & Director (Age 43, Pay $652.82k)
  • Mr. Joshua Kushner, Co-Founder & Vice Chairman (Age 37)
  • Mr. Richard Scott Blackley CPA, Chief Financial Officer (Age 54, Pay $759.43k)
  • Ms. Alessandrea Corinne Quane, Exec. VP & Chief Insurance Officer (Age 52, Pay $743.9k)
  • Ms. Victoria Baltrus, Chief Accounting Officer (Age 52)
  • Cornelia Miller, VP of Investor Relations
  • Ms. Ranmali Bopitiya, Chief Legal Officer
  • Mr. Joel I. Klein, Sr. Advisor (Age 75)
  • Dr. Dennis Weaver M.D., Chief Clinical Officer (Age 61) (LinkedIn Profile)
  • Dr. Okiki Louis, Pres of Oscar Medical Group

What is Mario T. Schlosser's approval rating as Oscar Health's CEO?

207 employees have rated Oscar Health CEO Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among Oscar Health's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

When did Oscar Health IPO?

(OSCR) raised $1 billion in an IPO on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

What is Oscar Health's stock symbol?

Oscar Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSCR."

How do I buy shares of Oscar Health?

Shares of OSCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oscar Health's stock price today?

One share of OSCR stock can currently be purchased for approximately $4.88.

How much money does Oscar Health make?

Oscar Health (NYSE:OSCR) has a market capitalization of $1.03 billion and generates $1.84 billion in revenue each year. The company earns $-572,610,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis.

How many employees does Oscar Health have?

Oscar Health employs 2,621 workers across the globe.

How can I contact Oscar Health?

Oscar Health's mailing address is 75 Varick Street 5th Floor, New York NY, 10013. The official website for Oscar Health is www.hioscar.com. The company can be reached via phone at 646-403-3677 or via email at ir@hioscar.com.

This page (NYSE:OSCR) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.